Calciphylaxis and its diagnosis: A review

Calciphylaxis also known as Calcific uremic arteriolopathy (CUA), is a rare fatal complication usually associated with end-stage renal disease (ESRD). It is characterized by skin ulceration and necrosis leading to significant pain. The disease calciphylaxis is pathological state resulting in accumulation of calcium content in medial wall of small blood vessels along with the fibrotic changes in intima. The aetiopathogenesis of this disease, small vessel vasculopathy, remains complicated, and unclear. It is believed that development of calciphylaxis depends on medial calcification, intimal fibrosis of arterioles and thrombotic occlusion. The disease is rare, life-threatening medical condition that occurs mostly in population with kidney disease or in patients on dialysis. Skin biopsy and radiographic features are helpful in the diagnosis of calciphylaxis, but negative results do not necessarily exclude the diagnosis. This article highlights steps undertaking in the diagnosis of calciphylaxis.

[1]  N. Ouzeddoun,et al.  Calciphylaxis: Successful Management of a Rare Complication of Chronic Kidney Disease in Two Patients , 2019, Case reports in nephrology.

[2]  John J Chang,et al.  Calciphylaxis: Diagnosis, Pathogenesis, and Treatment , 2019, Advances in skin & wound care.

[3]  S. Nigwekar,et al.  Review: update on the management of calciphylaxis , 2018, QJM : monthly journal of the Association of Physicians.

[4]  D. Cucchiari,et al.  Calciphylaxis in patients with chronic kidney disease: A disease which is still bewildering and potentially fatal. , 2018, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.

[5]  M. Pelletier-Galarneau,et al.  The Role of Bone Scintigraphy with Single-photon Emission Computed Tomography-computed Tomography in the Diagnosis and Evaluation of Calciphylaxis , 2017, World journal of nuclear medicine.

[6]  C. Huysentruyt,et al.  Acenocoumarol as a risk factor for calciphylaxis: a feature clinicians should be aware of. , 2017, The Netherlands journal of medicine.

[7]  E. Morales,et al.  Calciphylaxis: Beyond CKD-MBD. , 2017, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.

[8]  A. Dominguez,et al.  Calciphylaxis: Controversies in Pathogenesis, Diagnosis and Treatment , 2016, The American journal of the medical sciences.

[9]  William R. Lloyd,et al.  Raman spectroscopy for label-free identification of calciphylaxis. , 2015, Journal of biomedical optics.

[10]  M. Kamdar,et al.  Calciphylaxis: risk factors, diagnosis, and treatment. , 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[11]  M. Hoang,et al.  Cutaneous Calciphylaxis: A Retrospective Histopathologic Evaluation , 2013, The American Journal of dermatopathology.

[12]  R. Weenig,et al.  Net-like pattern of calcification on plain soft-tissue radiographs in patients with calciphylaxis. , 2012, Journal of the American Academy of Dermatology.

[13]  M. Hayden,et al.  Calcific uremic arteriolopathy , 2010, Oxidative medicine and cellular longevity.

[14]  R. Nazarian,et al.  Warfarin-induced skin necrosis. , 2009, Journal of the American Academy of Dermatology.

[15]  M. Hussein,et al.  Calciphylaxis cutis: a case report and review of literature. , 2009, Experimental and molecular pathology.

[16]  N. Rogers,et al.  Calcific uraemic arteriolopathy: an update , 2008, Current opinion in nephrology and hypertension.

[17]  J. D. Del Rosso,et al.  Calciphylaxis: a review. , 2008, The Journal of clinical and aesthetic dermatology.

[18]  R. Weenig Pathogenesis of calciphylaxis: Hans Selye to nuclear factor kappa-B. , 2008, Journal of the American Academy of Dermatology.

[19]  U. Brewster Dermatological disease in patients with CKD. , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[20]  Sharon M Moe,et al.  Mechanisms of vascular calcification in chronic kidney disease. , 2008, Journal of the American Society of Nephrology : JASN.

[21]  C. Aparici,et al.  Calciphylaxis and bone scintigraphy: case report with histological confirmation and review of the literature , 2007, Annals of nuclear medicine.

[22]  P. Coates,et al.  VASCULAR CALCIFICATION IN PATIENTS WITH KIDNEY DISEASE: Calcific Uremic Arteriolopathy: Advances in Pathogenesis and Treatment , 2007 .

[23]  K. Servilla,et al.  Association between calciphylaxis and inflammation in two patients on chronic dialysis. , 2006, Advances in peritoneal dialysis. Conference on Peritoneal Dialysis.

[24]  G. Kapur,et al.  Calciphylaxis in pediatric end-stage renal disease , 2005, Pediatric Nephrology.

[25]  G. Malka,et al.  [Calciphylaxis: a severe but unrecognized complication in end-stage renal disease patients. A review of 2 cases]. , 2005, Annales de chirurgie plastique et esthetique.

[26]  J. Dear,et al.  Calciphylaxis , 2003, The Lancet.

[27]  K. Eckardt,et al.  Bone morphogenic protein-4 expression in vascular lesions of calciphylaxis. , 2003, Journal of nephrology.

[28]  A. Schwarz,et al.  The serum protein α2–Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification , 2003 .

[29]  A. Lumsden,et al.  Calciphylaxis and nonhealing wounds: the role of the vascular surgeon in a multidisciplinary treatment. , 2003, Journal of vascular surgery.

[30]  A. Fine,et al.  Calciphylaxis is usually non-ulcerating: risk factors, outcome and therapy. , 2002, Kidney international.

[31]  S. Myers,et al.  Calciphylaxis in patients on hemodialysis: a prevalence study. , 1997, Surgery.

[32]  D. C. Henckel,et al.  Case report. , 1995, Journal.

[33]  H. Selye The dermatologic implications of stress and calciphylaxis. , 1962, The Journal of investigative dermatology.

[34]  H. Selye,et al.  Sensitization to calciphylaxis by endogenous parathyroid hormone. , 1962, Endocrinology.